BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33685320)

  • 1. Evaluation of the non-clinical toxicity of an antiparasitic agent: diminazene aceturate.
    da Silva Oliveira GL; da Silva APDSCL
    Drug Chem Toxicol; 2022 Sep; 45(5):2003-2013. PubMed ID: 33685320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice.
    Qiu Y; Shil PK; Zhu P; Yang H; Verma A; Lei B; Li Q
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3809-18. PubMed ID: 24854854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT
    Goru SK; Kadakol A; Malek V; Pandey A; Sharma N; Gaikwad AB
    Br J Pharmacol; 2017 Sep; 174(18):3118-3130. PubMed ID: 28688122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
    Qi Y; Zhang J; Cole-Jeffrey CT; Shenoy V; Espejo A; Hanna M; Song C; Pepine CJ; Katovich MJ; Raizada MK
    Hypertension; 2013 Oct; 62(4):746-52. PubMed ID: 23959549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches.
    Santos ES; Silva PC; Sousa PSA; Aquino CC; Pacheco G; Teixeira LFLS; Araujo AR; Sousa FBM; Barros RO; Ramos RM; Rocha JA; Nicolau LAD; Medeiros JVR
    Chem Biol Interact; 2022 Nov; 367():110161. PubMed ID: 36116513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminazene Aceturate, an angiotensin converting enzyme 2 (ACE2) activator, promotes cardioprotection in ischemia/reperfusion-induced cardiac injury.
    Coutinho DCO; Santos-Miranda A; Joviano-Santos JV; Foureaux G; Santos A; Rodrigues-Ferreira C; Martins-Júnior PA; Resende RR; Medei E; Vieyra A; Santos RAS; Cruz JS; Ferreira AJ
    Peptides; 2022 May; 151():170746. PubMed ID: 35033621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminazene aceturate improves autonomic modulation in pulmonary hypertension.
    Rigatto K; Casali KR; Shenoy V; Katovich MJ; Raizada MK
    Eur J Pharmacol; 2013 Aug; 713(1-3):89-93. PubMed ID: 23665493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats.
    Coutinho DC; Monnerat-Cahli G; Ferreira AJ; Medei E
    Europace; 2014 Nov; 16(11):1689-96. PubMed ID: 24741027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats.
    Foureaux G; Franca JR; Nogueira JC; Fulgêncio Gde O; Ribeiro TG; Castilho RO; Yoshida MI; Fuscaldi LL; Fernandes SO; Cardoso VN; Cronemberger S; Faraco AA; Ferreira AJ
    PLoS One; 2015; 10(7):e0133149. PubMed ID: 26204514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats?
    Badae NM; El Naggar AS; El Sayed SM
    Can J Physiol Pharmacol; 2019 Jul; 97(7):638-646. PubMed ID: 30840489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme 2 activator, DIZE in the basolateral amygdala attenuates the tachycardic response to acute stress by modulating glutamatergic tone.
    Silva CC; Correa AMB; Kushmerick C; Sharma NM; Patel KP; de Almeida JFQ; Moreira FA; Ferreira AJ; Fontes MAP
    Neuropeptides; 2020 Oct; 83():102076. PubMed ID: 32800589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminazene aceturate extenuate the renal deleterious consequences of angiotensin-II induced by γ-irradiation through boosting ACE2 signaling cascade.
    Hasan HF; Elgazzar EM; Mostafa DM
    Life Sci; 2020 Jul; 253():117749. PubMed ID: 32380079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminazene aceturate--An antiparasitic drug of antiquity: Advances in pharmacology & therapeutics.
    da Silva Oliveira GL; de Freitas RM
    Pharmacol Res; 2015 Dec; 102():138-57. PubMed ID: 26470648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats.
    Castardeli C; Sartório CL; Pimentel EB; Forechi L; Mill JG
    Biomed Pharmacother; 2018 Nov; 107():212-218. PubMed ID: 30092400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminazene aceturate (DIZE) has cellular and in vivo antiarrhythmic effects.
    Joviano-Santos JV; Santos-Miranda A; Joca HC; Cruz JS; Ferreira AJ
    Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):213-219. PubMed ID: 31643111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats.
    De Maria ML; Araújo LD; Fraga-Silva RA; Pereira LA; Ribeiro HJ; Menezes GB; Shenoy V; Raizada MK; Ferreira AJ
    Protein Pept Lett; 2016; 23(1):9-16. PubMed ID: 26458404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective effects of diminazene aceturate in pressure-overloaded rat hearts.
    Macedo LM; Souza ÁP; De Maria ML; Borges CL; Soares CM; Pedrino GR; Colugnati DB; Santos RA; Mendes EP; Ferreira AJ; Castro CH
    Life Sci; 2016 Jun; 155():63-9. PubMed ID: 27153779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.
    Foureaux G; Nogueira JC; Nogueira BS; Fulgêncio GO; Menezes GB; Fernandes SO; Cardoso VN; Fernandes RS; Oliveira GP; Franca JR; Faraco AA; Raizada MK; Ferreira AJ
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4296-306. PubMed ID: 23702784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-Converting Enzyme 2 Activation Mitigates Behavioral Deficits and Neuroinflammatory Burden in 6-OHDA Induced Experimental Models of Parkinson's Disease.
    Gupta S; Tiwari V; Tiwari P; Parul ; Mishra A; Hanif K; Shukla S
    ACS Chem Neurosci; 2022 May; 13(10):1491-1504. PubMed ID: 35533351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis.
    Zheng C; Lei C; Chen Z; Zheng S; Yang H; Qiu Y; Lei B
    Mol Vis; 2015; 21():403-11. PubMed ID: 25883526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.